Venus Remedies Limited (VENUSREM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.136x

Based on the latest financial reports, Venus Remedies Limited (VENUSREM) has a cash flow conversion efficiency ratio of 0.136x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs811.10 Million ≈ $8.77 Million USD) by net assets (Rs5.94 Billion ≈ $64.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Venus Remedies Limited (VENUSREM) defensive interval to measure how many days the company can operate on defensive assets alone.

Venus Remedies Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Venus Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Venus Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Venus Remedies Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shining Building Business Co Ltd TW:5531	0.006x
Waffer Technology Corp TW:6235	0.118x
Bank Ochrony Środowiska SA WAR:BOS	0.004x
Metalfrio Solutions S.A SA:FRIO3	0.428x
Burgenland Holding Aktiengesellschaft VI:BHD	N/A
SatixFy Communications Ltd NYSE MKT:SATX	0.081x
Dharma Polimetal Tbk PT JK:DRMA	0.093x
Kenmare Resources PLC IR:KMR	0.060x

Annual Cash Flow Conversion Efficiency for Venus Remedies Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Venus Remedies Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Venus Remedies Limited stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs5.61 Billion ≈ $60.66 Million	Rs909.20 Million ≈ $9.83 Million	0.162x	+111.94%
2024-03-31	Rs4.88 Billion ≈ $52.73 Million	Rs372.85 Million ≈ $4.03 Million	0.076x	-3.87%
2023-03-31	Rs4.60 Billion ≈ $49.78 Million	Rs366.20 Million ≈ $3.96 Million	0.080x	-14.55%
2022-03-31	Rs4.40 Billion ≈ $47.63 Million	Rs410.01 Million ≈ $4.43 Million	0.093x	-71.90%
2021-03-31	Rs4.00 Billion ≈ $43.29 Million	Rs1.33 Billion ≈ $14.34 Million	0.331x	+39.12%
2020-03-31	Rs3.23 Billion ≈ $34.97 Million	Rs770.10 Million ≈ $8.33 Million	0.238x	+74.71%
2019-03-31	Rs3.33 Billion ≈ $35.96 Million	Rs453.27 Million ≈ $4.90 Million	0.136x	-4.09%
2018-03-31	Rs3.62 Billion ≈ $39.14 Million	Rs514.36 Million ≈ $5.56 Million	0.142x	-35.64%
2017-03-31	Rs4.52 Billion ≈ $48.84 Million	Rs997.24 Million ≈ $10.78 Million	0.221x	+106.13%
2016-03-31	Rs4.38 Billion ≈ $47.33 Million	Rs468.81 Million ≈ $5.07 Million	0.107x	-27.85%
2015-03-31	Rs4.57 Billion ≈ $49.39 Million	Rs678.05 Million ≈ $7.33 Million	0.148x	+30.18%
2014-03-31	Rs4.62 Billion ≈ $49.92 Million	Rs526.46 Million ≈ $5.69 Million	0.114x	-17.09%
2013-03-31	Rs3.79 Billion ≈ $41.00 Million	Rs521.50 Million ≈ $5.64 Million	0.138x	+1.44%
2012-03-31	Rs3.07 Billion ≈ $33.23 Million	Rs416.70 Million ≈ $4.51 Million	0.136x	-13.98%
2011-03-31	Rs2.37 Billion ≈ $25.62 Million	Rs373.47 Million ≈ $4.04 Million	0.158x	-14.83%
2010-03-31	Rs1.71 Billion ≈ $18.51 Million	Rs316.83 Million ≈ $3.43 Million	0.185x	+35.37%
2009-03-31	Rs1.39 Billion ≈ $14.99 Million	Rs189.50 Million ≈ $2.05 Million	0.137x	-36.02%
2008-03-31	Rs889.86 Million ≈ $9.62 Million	Rs190.17 Million ≈ $2.06 Million	0.214x	-50.89%
2007-03-31	Rs551.31 Million ≈ $5.96 Million	Rs239.88 Million ≈ $2.59 Million	0.435x	+58.20%
2006-03-31	Rs318.96 Million ≈ $3.45 Million	Rs87.73 Million ≈ $948.76K	0.275x	--

About Venus Remedies Limited

NSE:VENUSREM India Drug Manufacturers - Specialty & Generic

Market Cap

$256.52 Million

Rs23.72 Billion INR

Market Cap Rank

#15643 Global

#788 in India

Share Price

Rs1774.50

Change (1 day)

-5.00%

52-Week Range

Rs425.80 - Rs1883.00

All Time High

Rs1883.00